Previously treated unresectable solid tumours research hub

A Phase I/Ib Dose Escalation and Cohort Expansion Study of OMX-0407 a Salt-inducible Kinase inhibitor in patients with previously treated unresectable solid tumours

This study is testing a new medicine, OMX-0407, for people with advanced cancers that can't be removed by surgery and have been treated before. It's an early-stage study to find a safe dose and see how well it works.